非酒精性脂肪性肝病与痴呆风险:一项基于人群的队列研究
该研究基于瑞典国家患者登记数据,纳入1987至2016年间65岁及以上非酒精性脂肪性肝病患者2898例,并按年龄、性别和市镇匹配28357名对照。中位随访5.5年期间,非酒精性脂肪性肝病组痴呆发生率为5.0%,对照组为4.6%,调整后风险比为1.38(95%CI 1.10-1.72);合并心脏病或卒中时风险更高。
要点
- 非酒精性脂肪性肝病与痴呆风险轻度升高相关(aHR 1.38,95%CI 1.10-1.72)。
- 非酒精性脂肪性肝病合并心脏病时痴呆风险aHR为1.50(95%CI 1.08-2.05)。
- 非酒精性脂肪性肝病合并卒中时痴呆风险aHR为2.60(95%CI 1.95-3.47)。
核心结论
- 非酒精性脂肪性肝病与痴呆发生率升高存在轻度关联,在合并心血管并发症的患者中该关联更强。
研究设计与样本
- 基于瑞典国家患者登记(NPR)的匹配队列研究,纳入1987至2016年确诊的65岁及以上非酒精性脂肪性肝病患者,按年龄、性别和市镇以最多1:10匹配一般人群对照。
主要发现
- 共纳入2898例非酒精性脂肪性肝病患者和28357名匹配对照,入组中位年龄70岁(四分位距8岁),女性占55.1%。
- 中位随访5.5年(四分位距8.5年)期间,非酒精性脂肪性肝病组145例(5.0%)和对照组1291例(4.6%)被诊断为痴呆。
- 与对照相比,非酒精性脂肪性肝病患者痴呆风险升高(aHR 1.38,95%CI 1.10-1.72),血管性痴呆风险为aHR 1.44(95%CI 0.96-2.23,p=0.07)。
- 非酒精性脂肪性肝病合并心脏病时痴呆风险aHR为1.50(95%CI 1.08-2.05),合并卒中时aHR为2.60(95%CI 1.95-3.47)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) and dementia share common risk factors including metabolic disorders. However, whether NAFLD is associated with dementia risk is unclear. We investigated the association between NAFLD and dementia risk as well as the role of cardiovascular complications including heart disease and stroke. METHODS: In this population-based matched cohort study, we identified all Swedish patients aged 65 years or older with NAFLD identified from the National Patient Register (NPR) between 1987 and 2016. These were matched with up to 10 reference individuals from the general population on age, sex, and municipality at the year of diagnosis. Incident dementia diagnosis was derived from the NPR or the Cause of Death Register until 2016. Adjusted hazard ratios (aHRs) and 95% CIs were estimated with Cox regression models. RESULTS: A total of 2,898 patients with NAFLD and 28,357 matched controls were identified (median age at entry, interquartile range [IQR], 70 [8]; 55.1% female). During a median follow-up of 5.5 years (IQR: 8.5 years), 145 (5.0%) patients with NAFLD and 1,291 (4.6%) reference individuals were diagnosed with dementia. Compared with the reference individuals, patients with NAFLD had higher rates of dementia (aHR 1.38, 95% CI 1.10-1.72) and vascular dementia (aHR 1.44, 95% CI 0.96-2.23, p = 0.07). Comorbid NAFLD and either heart disease (aHR 1.50 95% 1.08-2.05) or stroke (aHR 2.60 95% CI 1.95-3.47) conferred a greater risk of dementia. DISCUSSION: NAFLD had a modest association with increased rates of dementia. This was stronger among patients with NAFLD diagnosed with cardiovascular comorbidities. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that nonalcoholic fatty liver disease is associated with the development of vascular and nonvascular dementia.
引用
- Shang Y, Widman L, Hagström H, et al. Nonalcoholic Fatty Liver Disease and Risk of Dementia: A Population-Based Cohort Study. Neurology. 2022. PMID: 35831178. doi:10.1212/WNL.0000000000200853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。